Dry Eye Drugs Market in France - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 93 pages | ID: DC9CC5B57173EN
Market Monitor Global

Abstracts

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

This report contains market size and forecasts of Dry Eye Drugs in France, including the following market information:
France Dry Eye Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Dry Eye Drugs Market Consumption, 2015-2020, 2021-2026, (K Units)
France Dry Eye Drugs Production Capacity, 2015-2020, 2021-2026, (K Units)

Top Five Competitors in France Dry Eye Drugs Market 2019 (%)
The global Dry Eye Drugs market was valued at 6979.2 million in 2019 and is projected to reach US$ 10780 million by 2026, at a CAGR of 11.5% during the forecast period. While the Dry Eye Drugs market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dry Eye Drugs manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Dry Eye Drugs production and consumption in France

Total Market by Segment:

France Dry Eye Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
France Dry Eye Drugs Market Segment Percentages, By Type, 2019 (%)

• Artificial Tears
• Anti-inflammatory Drugs
• Other

France Dry Eye Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
France Dry Eye Drugs Market Segment Percentages, By Application, 2019 (%)

• Hospital
• Drug Stores
• Online Pharmacies

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Dry Eye Drugs Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Dry Eye Drugs Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Dry Eye Drugs Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total France Dry Eye Drugs Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:

• Allergan
• Novartis AG
• Bausch Health
• Santen Pharma
• Takeda
• Johnson & Johnson
• United Laboratories
• Senju Pharmaceutical
• Jianfeng Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dry Eye Drugs Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 France Dry Eye Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: FRANCE DRY EYE DRUGS OVERALL MARKET SIZE

2.1 France Dry Eye Drugs Market Size: 2020 VS 2026
2.2 France Dry Eye Drugs Revenue, Prospects & Forecasts: 2015-2026
2.3 France Dry Eye Drugs Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Dry Eye Drugs Players in France (including Foreign and Local Companies)
3.2 Top France Dry Eye Drugs Companies Ranked by Revenue
3.3 France Dry Eye Drugs Revenue by Companies (including Foreign and Local Companies)
3.4 France Dry Eye Drugs Sales by Companies (including Foreign and Local Companies)
3.5 France Dry Eye Drugs Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Dry Eye Drugs Companies in France, by Revenue in 2019
3.7 France Manufacturers Dry Eye Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dry Eye Drugs Players in France
  3.8.1 List of France Tier 1 Dry Eye Drugs Companies
  3.8.2 List of France Tier 2 and Tier 3 Dry Eye Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - France Dry Eye Drugs Market Size Markets, 2020 & 2026
  4.1.2 Artificial Tears
  4.1.3 Anti-inflammatory Drugs
  4.1.4 Other
4.2 By Type - France Dry Eye Drugs Revenue & Forecasts
  4.2.1 By Type - France Dry Eye Drugs Revenue, 2015-2020
  4.2.2 By Type - France Dry Eye Drugs Revenue, 2021-2026
  4.2.3 By Type - France Dry Eye Drugs Revenue Market Share, 2015-2026
4.3 By Type - France Dry Eye Drugs Sales & Forecasts
  4.3.1 By Type - France Dry Eye Drugs Sales, 2015-2020
  4.3.2 By Type - France Dry Eye Drugs Sales, 2021-2026
  4.3.3 By Type - France Dry Eye Drugs Sales Market Share, 2015-2026
4.4 By Type - France Dry Eye Drugs Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - France Dry Eye Drugs Market Size, 2020 & 2026
  5.1.2 Hospital
  5.1.3 Drug Stores
  5.1.4 Online Pharmacies
5.2 By Application - France Dry Eye Drugs Revenue & Forecasts
  5.2.1 By Application - France Dry Eye Drugs Revenue, 2015-2020
  5.2.2 By Application - France Dry Eye Drugs Revenue, 2021-2026
  5.2.3 By Application - France Dry Eye Drugs Revenue Market Share, 2015-2026
5.3 By Application - France Dry Eye Drugs Sales & Forecasts
  5.3.1 By Application - France Dry Eye Drugs Sales, 2015-2020
  5.3.2 By Application - France Dry Eye Drugs Sales, 2021-2026
  5.3.3 By Application - France Dry Eye Drugs Sales Market Share, 2015-2026
5.4 By Application - France Dry Eye Drugs Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Allergan
  6.1.1 Allergan Corporate Summary
  6.1.2 Allergan Business Overview
  6.1.3 Allergan Dry Eye Drugs Major Product Offerings
  6.1.4 Allergan Sales and Revenue in France (2015-2020)
  6.1.5 Allergan Key News
6.2 Novartis AG
  6.2.1 Novartis AG Corporate Summary
  6.2.2 Novartis AG Business Overview
  6.2.3 Novartis AG Dry Eye Drugs Major Product Offerings
  6.2.4 Novartis AG Sales and Revenue in France (2015-2020)
  6.2.5 Novartis AG Key News
6.3 Bausch Health
  6.3.1 Bausch Health Corporate Summary
  6.3.2 Bausch Health Business Overview
  6.3.3 Bausch Health Dry Eye Drugs Major Product Offerings
  6.3.4 Bausch Health Sales and Revenue in France (2015-2020)
  6.3.5 Bausch Health Key News
6.4 Santen Pharma
  6.4.1 Santen Pharma Corporate Summary
  6.4.2 Santen Pharma Business Overview
  6.4.3 Santen Pharma Dry Eye Drugs Major Product Offerings
  6.4.4 Santen Pharma Sales and Revenue in France (2015-2020)
  6.4.5 Santen Pharma Key News
6.5 Takeda
  6.5.1 Takeda Corporate Summary
  6.5.2 Takeda Business Overview
  6.5.3 Takeda Dry Eye Drugs Major Product Offerings
  6.5.4 Takeda Sales and Revenue in France (2015-2020)
  6.5.5 Takeda Key News
6.6 Johnson & Johnson
  6.6.1 Johnson & Johnson Corporate Summary
  6.6.2 Johnson & Johnson Business Overview
  6.6.3 Johnson & Johnson Dry Eye Drugs Major Product Offerings
  6.6.4 Johnson & Johnson Sales and Revenue in France (2015-2020)
  6.6.5 Johnson & Johnson Key News
6.7 United Laboratories
  6.6.1 United Laboratories Corporate Summary
  6.6.2 United Laboratories Business Overview
  6.6.3 United Laboratories Dry Eye Drugs Major Product Offerings
  6.4.4 United Laboratories Sales and Revenue in France (2015-2020)
  6.7.5 United Laboratories Key News
6.8 Senju Pharmaceutical
  6.8.1 Senju Pharmaceutical Corporate Summary
  6.8.2 Senju Pharmaceutical Business Overview
  6.8.3 Senju Pharmaceutical Dry Eye Drugs Major Product Offerings
  6.8.4 Senju Pharmaceutical Sales and Revenue in France (2015-2020)
  6.8.5 Senju Pharmaceutical Key News
6.9 Jianfeng Group
  6.9.1 Jianfeng Group Corporate Summary
  6.9.2 Jianfeng Group Business Overview
  6.9.3 Jianfeng Group Dry Eye Drugs Major Product Offerings
  6.9.4 Jianfeng Group Sales and Revenue in France (2015-2020)
  6.9.5 Jianfeng Group Key News
6.10 Eusan GMBH
  6.10.1 Eusan GMBH Corporate Summary
  6.10.2 Eusan GMBH Business Overview
  6.10.3 Eusan GMBH Dry Eye Drugs Major Product Offerings
  6.10.4 Eusan GMBH Sales and Revenue in France (2015-2020)
  6.10.5 Eusan GMBH Key News

7 DRY EYE DRUGS PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Dry Eye Drugs Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
  7.1.1 France Dry Eye Drugs Production Capacity, 2015-2026
  7.1.2 France Dry Eye Drugs Production 2015-2026
  7.1.3 France Dry Eye Drugs Production Value 2015-2026
7.2 Key Local Dry Eye Drugs Manufacturers in France
  7.2.1 France Key Local Dry Eye Drugs Manufacturers Production Capacity
  7.2.2 France Key Local Dry Eye Drugs Manufacturers Production
  7.2.3 France Key Local Dry Eye Drugs Manufacturers Production Value
  7.2.4 The Proportion of Dry Eye Drugs Production Sold in France and Sold Other Than France by Manufacturers
7.3 Dry Eye Drugs Export and Import in France
  7.3.1 France Dry Eye Drugs Export Market
  7.3.2 France Dry Eye Drugs Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for France Dry Eye Drugs Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON DRY EYE DRUGS SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Dry Eye Drugs Distributors and Sales Agents in France

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Dry Eye Drugs in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Dry Eye Drugs Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Dry Eye Drugs Revenue Share by Companies, 2015-2020
Table 5. France Dry Eye Drugs Sales by Companies, (K Units), 2015-2020
Table 6. France Dry Eye Drugs Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Dry Eye Drugs Price (2015-2020) (USD/Unit)
Table 8. France Manufacturers Dry Eye Drugs Product Type
Table 9. List of France Tier 1 Dry Eye Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Dry Eye Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Dry Eye Drugs Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Dry Eye Drugs Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Dry Eye Drugs Sales in France (K Units), 2015-2020
Table 14. By Type - Dry Eye Drugs Sales in France (K Units), 2021-2026
Table 15. By Application - Dry Eye Drugs Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Dry Eye Drugs Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Dry Eye Drugs Sales in France, (K Units), 2015-2020
Table 18. By Application - Dry Eye Drugs Sales in France, (K Units), 2021-2026
Table 19. Allergan Corporate Summary
Table 20. Allergan Dry Eye Drugs Product Offerings
Table 21. Allergan Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Novartis AG Corporate Summary
Table 23. Novartis AG Dry Eye Drugs Product Offerings
Table 24. Novartis AG Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Bausch Health Corporate Summary
Table 26. Bausch Health Dry Eye Drugs Product Offerings
Table 27. Bausch Health Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Santen Pharma Corporate Summary
Table 29. Santen Pharma Dry Eye Drugs Product Offerings
Table 30. Santen Pharma Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Takeda Corporate Summary
Table 32. Takeda Dry Eye Drugs Product Offerings
Table 33. Takeda Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Johnson & Johnson Corporate Summary
Table 35. Johnson & Johnson Dry Eye Drugs Product Offerings
Table 36. Johnson & Johnson Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 37. United Laboratories Corporate Summary
Table 38. United Laboratories Dry Eye Drugs Product Offerings
Table 39. United Laboratories Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 40. Senju Pharmaceutical Corporate Summary
Table 41. Senju Pharmaceutical Dry Eye Drugs Product Offerings
Table 42. Senju Pharmaceutical Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 43. Jianfeng Group Corporate Summary
Table 44. Jianfeng Group Dry Eye Drugs Product Offerings
Table 45. Jianfeng Group Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 46. Eusan GMBH Corporate Summary
Table 47. Eusan GMBH Dry Eye Drugs Product Offerings
Table 48. Eusan GMBH Dry Eye Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 49. Dry Eye Drugs Production Capacity (K Units) of Local Manufacturers in France, 2015-2020
Table 50. Dry Eye Drugs Production (K Units) of Local Manufacturers in France, 2015-2020
Table 51. France Dry Eye Drugs Production Market Share of Local Manufacturers, 2015-2020
Table 52. Dry Eye Drugs Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 53. France Dry Eye Drugs Production Value Market Share of Local Manufacturers, 2015-2020
Table 54. The Percentage of Dry Eye Drugs Production Sold in France and Sold Other Than France by Manufacturers
Table 55. The Percentage of Dry Eye Drugs Production Sold in France and Sold Other Than France by Manufacturers
Table 56. Dangeguojia Dry Eye Drugs Sales (Consumption), Production, Export and Import, 2015-2020
Table 57. Raw Materials and Suppliers
Table 58. Dry Eye Drugs Downstream Clients in France
Table 59. Dry Eye Drugs Distributors and Sales Agents in France

List Of Figures

LIST OF FIGURES

Figure 1. Dry Eye Drugs Segment by Type
Figure 2. Dry Eye Drugs Segment by Application
Figure 3. Dangeguojia Dry Eye Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Dry Eye Drugs Market Size in France, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. France Dry Eye Drugs Revenue, 2015-2026 (US$, Mn)
Figure 7. Dry Eye Drugs Sales in France: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dry Eye Drugs Revenue in 2019
Figure 9. By Type - France Dry Eye Drugs Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Dry Eye Drugs Market Share, 2015-2020
Figure 11. By Type - France Dry Eye Drugs Market Share, 2020-2026
Figure 12. By Type - France Dry Eye Drugs Price (USD/Unit), 2015-2026
Figure 13. By Application - Dry Eye Drugs Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Dry Eye Drugs Market Share, 2015-2020
Figure 15. By Application - France Dry Eye Drugs Market Share, 2020-2026
Figure 16. By Application -France Dry Eye Drugs Price (USD/Unit), 2015-2026
Figure 17. France Dry Eye Drugs Production Capacity (K Units), 2015-2026
Figure 18. France Dry Eye Drugs Actual Output (K Units), 2015-2026
Figure 19. France Dry Eye Drugs Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Dry Eye Drugs Export Destination, 2019
Figure 21. The Source of Imports of France Dry Eye Drugs, 2019
Figure 22. PEST Analysis for France Dry Eye Drugs Market in 2020
Figure 23. Dry Eye Drugs Market Opportunities & Trends in France
Figure 24. Dry Eye Drugs Market Drivers in France
Figure 25. Dry Eye Drugs Market Restraints in France
Figure 26. Dry Eye Drugs Industry Value Chain